1910
Multimodal AI Platform for Modality Agnostic Drug Discovery™
AI-powered Drug Discovery
About
We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.
Build your own investing agent
GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.
Join the GPAgent waitlistDetails
Status
Active
Stage
Growth
Team Size
20
Regions
United States of America, America / Canada